Zhang Z X, Yang L, Young K J, DuTemple B, Zhang L
Department of Laboratory of Medicine and Pathobiology, Multi Organ Transplantation Program, Toronto General Hospital Research Institute, UHN, University of Toronto, Toronto, M5G, 2C4, Canada.
Nat Med. 2000 Jul;6(7):782-9. doi: 10.1038/77513.
Despite increasing evidence for the existence of antigen-specific regulatory T cells, the mechanisms underlying suppression remain unclear. In this study we have identified and cloned a novel subset of antigen-specific regulatory T cells and demonstrated that these T cells possess a unique combination of cell surface markers and array of cytokines. The regulatory T cells are able to inhibit the function of T cells carrying the same T-cell receptor specificity and prevent skin allograft rejection in an antigen-specific, dose-dependent manner. The regulatory T cells are able to acquire alloantigen from antigen-presenting cells, present the alloantigen to activated syngeneic CD8+ T cells and then send death signals to CD8+ T cells. These findings provide a novel mechanism of regulatory T-cell-mediated, antigen-specific suppression.
尽管越来越多的证据表明存在抗原特异性调节性T细胞,但抑制作用的潜在机制仍不清楚。在本研究中,我们鉴定并克隆了一个新的抗原特异性调节性T细胞亚群,并证明这些T细胞具有独特的细胞表面标志物组合和细胞因子阵列。调节性T细胞能够抑制携带相同T细胞受体特异性的T细胞功能,并以抗原特异性、剂量依赖性方式预防皮肤同种异体移植排斥反应。调节性T细胞能够从抗原呈递细胞获取同种异体抗原,将同种异体抗原呈递给活化的同基因CD8+T细胞,然后向CD8+T细胞发送死亡信号。这些发现提供了一种调节性T细胞介导的抗原特异性抑制的新机制。